Medis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments

Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).

Founded in 1989, Medis Medical Imaging Systems B.V. provides high-quality quantitative analysis solutions for cardiovascular imaging to the medical community. Medis’ software is internationally appreciated due to its ease of use and clinical outcomes for patients. The company continuously focuses on creating, researching and innovating towards clinically relevant software solutions in the field of cardiovascular imaging.

Oaklins’ team in the Netherlands acted as the exclusive strategic advisor to the shareholders and management of Medis Medical Imaging Systems B.V.

Servicio

Financiamiento, asesoría en deuda & ECM

Partes

“We are delighted to be taking this next step with GE HealthCare, a fellow leader in the interventional cardiology domain. Building on Medis QFR’s decade of AI research, customer-focused product development, clinical evidence generation and business development, we are excited to be able to further accelerate our efforts around Medis QFR to enable more hospitals and clinicians to apply physiology in day-to-day interventional practice as part of clinical care best practices, making this technology more accessible and available to patients than ever before.”

Maya Barley

CEO, Medis Medical Imaging Systems B.V.

Contáctese con el equipo de la transacción

Martijn de Win

Director

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Robert Boersma

Socio

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Robbert Bon

Asociado Senior

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Baran Temur

Asociado Senior

Amsterdam, Países Bajos
Oaklins Netherlands

Ver perfil Contáctenos

Transacciones relacionadas

Bayer AG has entered into a takeover agreement with Cara Care

Salud | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Aprenda más

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

Private Equity | Servicios de Soporte Comercial | Servicios Financieros | TMT

Grupo Veta 2017 S.L. has been acquired by MSA Mizar

The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.

Aprenda más

Saideep Healthcare and Research has raised equity

Salud

Saideep Healthcare and Research has raised equity

Saideep Healthcare and Research Private Limited has successfully completed a fundraising. This funding will help Saideep become a leading healthcare brand, offering advanced specialties across the region. The funds from this collaboration will be used to diversify into new and complex specialties, expand infrastructure and meet the growing demand for high-quality healthcare services in Western India.

Aprenda más